SlideShare a Scribd company logo
1 of 5
Download to read offline
www.flemingeurope.com
Organized by
MEET THE MEMBERS OF OUR SPEAKER PANEL
Lisa Egbuonu-Davis
MD, MPH, MBA, Sanofi, USA
Vice President Global Patient
Centered Outcomes and
Solutions
Elizabeth Adams
Irish Nurses and Midwives
Organisation, Ireland
Director of Professional
Development
Giora Sharf
CML Advocate Network, Israel
Patient Advocate and Board
Member
Michael Seres
The Patient Association, UK
Patient Ambassador
See the whole speaker panel on the second page
BENEFITS OF ATTENDING
•	 Learn from UCB how to effectively engage patients
•	 Get inspired by the award winning project Connecting Nurses by Sanofi
•	 Discover what it means to be a patient in the 21st
century
•	 Learn about the daily challenges influencing adherence of chronic
patients from patients themselves
•	 Get your hands on practical advice from Teva on building an effective
patient support team
•	 Gain insight into the world of adherence digital health media
SPECIAL FEATURES
•	 fast-fire session
•	 award-winning case study
•	 workshop
•	 roundtable discussions
•	 hands-on try-out of digital health
applications
•	 spotlight session
Media Partners
25 - 26
February 2016
Amsterdam
THE NETHERLANDS
Patient Adherence
and Compliance
Masterclass
„Join forces with other stakeholders and make progress in improving adherence.“
MASTERCLASS INTRODUCTION
The pharmaceutical industry is undergoing changes, and is shifting
towards patient centricity. Innovative outlooks and patient insights
bring a new weapon to the battle against established challenges.
Non-adherence increases medical costs, creates waste in medical
spending, multiplies the number of hospitalisations and threatens
lives. The issue touches all stakeholders involved in healthcare:
from the pharmaceutical companies to doctors to the patients
themselves. Therefore, effective improvement is possible only
through the cooperation of multiple stakeholders.
Improve stakeholder collaboration, build lasting relationships,
learn about the challenges of others and improve adherence for
the benefit of all. Whether you are an industry representative, a
medical doctor, a health insurance representative or a member of a
patient organisation, the Patient Adherence and Compliance
Masterclass is the perfect opportunity to join forces with other
stakeholders and make progress in improving adherence.
SPEAKER PANEL
Lisa Egbuonu-Davis
MD, MPH, MBA
Sanofi, USA
Vice President Global
Patient Centered Outcomes
and Solutions
Sylvie Coumel
Sanofi, France
Connecting Nurses &
Patient Empowerment
Director Global Patient-
Centered Outcomes and
Solutions
Danielle Derijcke
UCB, Belgium
Patient Affairs Officer
Elizabeth Adams
Irish Nurses and Midwives
Organisation, Ireland
Director of Professional
Development
Rebecca Reeve
Sanofi, UK
Head of Professional
Relations, Diabetes
Søren Eik Skovlund
Novo Nordisk, Denmark
Global Director, Global
Senior Health Economics
and Outcomes Research
Manager, DAWN Studies
Ana Maria Arboleda
Teva Europe
Director of Operations,
Patient Solutions Europe
Natalia Forsyth
Novartis, Switzerland
Digital Health Strategist
Dr. Stefan Becker
University Hospital Essen
Germany
Consultant Physician
Rachel Jones
AstraZeneca, UK
Patient Centricity Project
lead, Qualified Pharmacist
Marcel Kooij
Utrecht University
The Netherlands
Pharmacist
Giora Sharf
CML Advocate
Network, Israel
Patient Advocate and Board
Member
Bettina Ryll
Melanoma Patient
Network Europe, Sweden
Founder
Michael Seres
The Patient
Association, UK
Patient Ambassador
Paul Buchanan
Team Blood Glucose, UK
CEO and Founder
David SANgster
1in20Parkinsons, UK
Founder
Jerry van Gessel
Parkinson‘s on the Move
The Netherlands
Board Member
Joep Welling
NVLE – The Dutch Patient
Organization for Systemic
Autoimmune Diseases
The Netherlands
Chair and former President
Lia Le Roy
Brain Tumor Support
Group, The Netherlands
Chair
YOU WILL MEET
Patients‘ Groups, Organizations and Associations, Pharmacists, Medical Doctors and Healthcare Providers, Medical Associations
and Organizations, C-level Pharmaceutical Industry Executives along with Directors, Heads and Managers of: Patient Engagement,
Support, Advocacy, Communication, Experience, Affairs, Adherence, Relationships, Assistance and others...
Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490
Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
DAY 1
8:30	 MORNING COFFEE  REGISTRATION
9:00	 WELCOME NOTE FROM FLEMING EUROPE
9:05	 OPENING REMARKS FROM THE CHAIRMAN
UNDERSTANDING ADHERENCE FROM
THE PATIENT‘S PERSPECTIVE
9:15	 FAST-FIRE SESSION
20 very fast “YES/NO” questions addressed by the masterclass
keynote speaker
9:20	 KEYNOTE: THE MULTI-DIMENSIONAL ISSUE OF
PATIENT ADHERENCE
•	 The need for a multi-perspective approach
•	 Reasons for non-adherence
•	 Creating links and relationships between stakeholders
9:50	 PATIENT EMPOWERMENT: MAKE PATIENTS YOUR
PARTNERS IN HEALTHCARE
•	 Educating patients and making them confident about
their treatment
•	 Advocating adherence on all platforms
•	 Tips for building patient-centric content
•	 QA
Lisa Egbuonu-Davis MD, MPH, MBA, Sanofi, USA
Vice President Global Patient Centered Outcomes and
Solutions
10:20	 HOW TO PREPARE YOUR ORGANIZATION FOR
EFFECTIVE PATIENT ENGAGEMENT
•	 Ingredients for successful patient engagement
•	 Compliance to regulations
•	 Ready, set, engage!
Danielle Derijcke, UCB, Belgium
Patient Affairs Officer
10:50	 MORNING COFFEE  NETWORKING
11:10	 THE 21st
CENTURY PATIENT
•	 What does it mean to be a long term patient in the 21st
Century
•	 How does technology play a role
•	 Are co-production and shared outcomes buzz
words or a reality
•	 How do patients share their data now
Michael Seres, The Patient Association, UK
Patient Ambassador
11:40	A DAY IN THE LIFE OF A PATIENT WITH A CHRONIC
ILLNESS
•	 Focus on the daily challenges brought by a strict
medication regime
•	 Learning about the individual needs of chronic patients
•	 What needs to be done to manage non-adherence
•	 QA
David Sangster, 1in20Parkinsons, UK, Founder
Paul Buchanan, Team Blood Glucose, UK
CEO and Founder
Jerry van Gessel, Parkinson‘s on the Move
The Netherlands, Board Member
Michael Seres, The Patient Association, UK
Patient Ambassador
12:20	LUNCHEON
13:40	ROUNDTABLE DISCUSSION
•	 Topic 1. The Role and Importance of Patient Support
Groups in Battling Non-adherence
•	 Topic 2. The Engagement of Patients in Research and
Development
•	 Topic 3. A Family Perspective on Chronic Disease and
Adherence
•	 Topic 4. Patient Education: The Key to Better Disease
Management and Finding the Correct Treatment
Lia Le Roy, Brain Tumor Support group
The Netherlands, Chair
Rachel Jones, AstraZeneca, UK, Patient Centricity
Project Lead, Qualified Pharmacist
Jerry van Gessel, Parkinson‘s on the Move
The Netherlands, Board Member
Joep Welling, NVLE – The Dutch Patient
Organization for Systemic Autoimmune Diseases
the Netherlands, Chair and former President
MEDICATION ADHERENCE AND DIGITAL MEDIA
14:30	ENGAGING PATIENTS THROUGH DIGITAL HEALTH MEDIA
•	 The priceless opportunity of getting real-time feedback
•	 Using detailed data to create a personalized regime
•	 Pinpointing the best digital health media and ideas for
their application
•	 QA
Natalia Forsyth, Novartis, Switzerland
Digital Health Strategist
Paul Buchanan, Team Blood Glucose, UK
CEO and Founder
David Sangster, 1in20Parkinsons, UK, Founder
15:10	GAMIFIED ADHERENCE: DIGITAL HEALTH APPLICATIONS
•	 Practical demonstrations
•	 Hands-on try-out
•	 QA
Rebecca Reeve, sanofi-aventis, UK
Head of Professional Relations, Diabetes
15:40	 COFFEE BREAK  NETWORKING
16:00	IMPROVING ADHERENCE BY mHEALTH
•	 Can mHealth technology support chronically ill patients in
the management of their disease and improve adherence?
•	 Technical adherence as a precondition for medical adherence:
Can we predict, who will use such technology long-term?
•	 How can we evaluate such interventions?
Dr. Stefan Becker, University Hospital Essen, Germany
Consultant Physician
16:30	DISCUSSION: THE MOST SUCCESSFUL WAYS OF
APPROACHING PATIENTS
Approaching patients and getting valuable insights represents
one of the biggest problems in creating adherence solutions.
Adopt an ethical approach and learn from industry leaders
about the best ways to reach customers.
Featuring speakers from day1
Topics to be covered and discussed:
•	 The need for an ethical approach to patients
•	 The key principles of Trust and Respect
•	 Practical methods for gaining patients‘ insights
17:55	 FEEDBACK SESSION
17:55	 CLOSING REMARKS FROM THE CHAIR
18:00	 Speakers and delegates are cordially invited to
attend a NETWORKING COCKTAIL RECEPTION
compliments of FLEMING EUROPE
Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490
Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
8:30	 MORNING COFFEE  NETWORKING
9:00	 OPENING REMARKS FROM THE CHAIR
MULTIPLE-STAKEHOLDER COOPERATION
9:05	IMPROVING ADHERENCE THROUGH SUSTAINABLE
STAKEHOLDER COLLABORATION
•	 Communication with various stakeholders
•	 Building sustainable, people-centred and collaborative
health care
•	 Applying the principles of transparency and
communication in practice
Søren Eik Skovlund, Novo Nordisk, Denmark
Global Director, Global Senior Health Economics and
Outcomes Research Manager, DAWN Studies
9:30	AWARD-WINNING CASE STUDY: CONNECTING NURSES
Learn about the ideas behind the winner of the Ad Age
Healthcare Impact GOLD Award, making it possible for
the nurse community to share valuable content and
implement ideas improving healthcare worldwide.
Sylvie Coumel, Sanofi, France
Connecting Nurses  Patient Empowerment Director
Global Patient-Centered Outcomes and Solutions
10:00	 SUPPORTING PATIENTS: PHARMACY BASED
INTERVENTIONS TO IMPROVE MEDICATION ADHERENCE
•	 The role of pharmacists in improving adherence
•	 Building a relationship with the patients
•	 Succesful Interventions in a pharmacy
•	 QA
Marcel Kooij, Utrecht University, The Netherlands
Pharmacist
10:30	 MORNING COFFEE  NETWORKING
11:00	 SUPPORT, CARE AND UNDERSTANDING: NURSES AND
ADHERENCE
•	 A direct and personal approach to patients
•	 Professional development of nurses in the new era of
healthcare
•	 Improving health literacy and overcoming adherence
barriers
Elizabeth Adams, Irish Nurses and Midwives
Organisation, Ireland, Director of Professional
Development
IMPROVING ADHERENCE
11:35	ADHERENCE IN CML: RESEARCH BY THE CML
ADVOCATES NETWORK
•	 Results of an extensive study of over 2500 CML
patients in 79 countries
•	 Reasons for non-adherence
•	 Possible solutions based on the results
Giora Sharf, CML Advocate Network, Israel
Patient Advocate and Board Member
12:00	LUNCHEON
13:30	 METHODOLOGY OF MEANINGFUL INTERACTION
•	 Understanding adherence and non-adherence
•	 Prevalent misconceptions about patients’ motivation
•	 Addressing the underlying issues and increasing
intrinsic motivation
Bettina Ryll, Melanoma Patient Network
Europe, Sweden, Founder
14:00	 WORKSHOP: HOW TO CREATE AN EFFECTIVE PATIENT
SUPPORT TEAM
Employ your strategic thinking and get valuable advice
from successful professionals at an interactive session on
stakeholder involvement within the circle of patient care
Topics to be covered and discussed:
•	 Discuss the best support team structure and program
goals
•	 Learn how to achieve better self-management and
adherence rates
•	 Discover solutions which help to overcome treatment
issues
Workshop leader:
Ana Maria Arboleda, Teva Europe
Director of Operations, Patient Solutions Europe
15:35	 FEEDBACK SESSION
15:45	 CLOSING REMARKS FROM THE CHAIR
15:50	 FAREWELL COFFEE  TEA
I would like to thank everyone who has helped with the research
and organization of this event – especially the advisers and
speakers – for their support and commitment.
Stanislava Nichtova, Conference and Masterclass Producer
stanislava.nichtova@flemingeurope.com
DAY 2Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490
Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
Patient Adherence and Compliance Masterclass
25 - 26 February 2016, Amsterdam, THE NETHERLANDS
Terms and Conditions:
These terms and conditions represent an integral part of this contract between Event Production, s.r.o. and a client, which is specified
above, and who by signing this registration form fully and without any doubt or uncertainty accepts all following terms and conditions:
1. Payment terms. Event Production, s.r.o. (hereinafter as “EP”) requires the full payment of the invoiced amount within 7
working days from the issue date of the invoice. EP reserves the right to refuse entry to any client who does not pay the invoice
in full and on time. If the payment is not received on EP’s account on the seventh day from the date of the issue of the invoice, EP is
entitled to charge the Client an overdue interest of 5% p.a. for every day, for which the Cleint’s payment is overdue. The registration
fee includes: conference documentation, admission to all conference sessions, lunches and refreshments, admission to networking social
breaks during the event. The registration fee does not include: travel, hotel accommodation, transfers or insurance.
2. Hotel accommodation. Overnight accommodation is not included in the registration fee. A reduced rate may be available for EP’s
clients at the hotel hosting the event. The reservation form will be sent to the client after the venue has been confirmed, but no later
than one month before the event begins.
3. Cancellation by client. The client has the right to cancel his/her participation in the event. Cancellation must be received by EP in
writing, either by mail, email or fax. If the client cancels with more than one month’s advance notice before the start of the event, EP
shall be entitled to retain and charge 50% of the total invoiced amount. If the client cancels with one month’s (or less) advance notice,
or fails to attend the event, then the client shall not be entitled to any refund nor any discount. Client’s failure to attend the event does
not cancel, decrease or in any matter waives the client’s obligation to fully pay the fee invoiced to the client by EP.
4. Cancellation by EP. While every reasonable effort is made to adhere to the advertised program, circumstances out of the control of
EP can arise, which may cause changes in the program, including but not limited to changes in the content, date(s), location or venue,
or special features of the planned event. Such circumstances include but are not limited to acts of terrorism, war, extreme weather
conditions, compliance with government requests, orders and legal requirements, failure of third party suppliers to timely deliver, and
failure to register the minimum targeted amount of attendees for a given event. EP reserves the right to change the content, date(s),
location or venue and/or special features of an event, to merge the event with another event, or to postpone it or cancel it entirely as
appropriate under the circumstances.  Client agrees that EP shall not be liable for any cost, damage or expense which may be incurred
by client as a consequence of the event being changed, merged with another event, postponed or cancelled and client agrees to hold
EP harmless and to indemnify EP for any liability caused by any such changes, mergers, postponements or cancellations to the Client.
5. Cancellation of the event. In case EP cancels the event, EP may offer the client a full credit up to the amount actually paid by the
client to EP. This credit shall be valid for up to one year from the issue date of the invoice to attend any of EP’s events. The client shall
not be entitled to this credit as a contractual right.
6. Clients identification information. By signing of this sales contract and these terms and conditions the client gives full right to EP
to share the client’s identification information such as, but not limited to, client’s name, address, email addresses, phone numbers and
names of representatives with third parties, which participated on the same event as the client.
7. Governing law. This contract shall be governed and construed in accordance with the laws of the Slovak Republic (not including its
conflict of laws provisions).  Any disputes arising out of this contract shall be brought before the courts of the Slovak Republic situated
in the city of Bratislava in the Slovak Republic.
8. Other currencies. In case that client requests payment in other than EP’s official currency (EUR), EP reserves the right to apply 8%
currency risk surcharge to the actual exchange rate.
Mlynské Nivy 71, 821 05 Bratislava, Slovakia
IČO: 44 59 74 52, IČ DPH: SK2022754448
1
Sales Contract	 Conference Code: BALS181
Please complete this form and send it back to:
E-mail to: killian.mabena@flemingeurope.com
or FAX.:  + 421 255 644 490
Client Identification Details
(Please complete form IN CAPITAL LETTERS for each client)
Ms 	 Mrs 	 Mr Surname: 
Name: 
Job Title: 
Email: 
Ms 	 Mrs 	 Mr Surname: 
Name: 
Job Title: 
Email: 
Ms 	 Mrs 	 Mr Surname: 
Name: 
Job Title: 
Email: 
Company/organisation Details
Name: 
VAT Number: 
(VAT No. for EU members / Tax Number for non-EU members)
Contact person: 
Email: 
Address: 
City: 
Country: 
Phone: 
Under European Union and Dutch tax regulations delegates are required to pay VAT in any
conference taking place in Netherlands. Delegates may be entitled to reclaim this cost.
Payment Method
Please debit my
Visa	 Eurocard/Mastercard Diners club
Card Billing Address: 
Street: 
City: 
Post/Zip Code
Card Holder´s Name: 
Card Holder´s Signature: 
Card Number: 
	 Visa CVC Number or Eurocard/Mastercard CVV Number
	 (last 3 digits on the back of the card)
Valid from	 	Expiry Date	
I agree to Event Production s.r.o. debiting my card.
Authorization and Acceptance of
Sales contract  Terms  Conditions
I hereby declare I am authorised to sign this contract and terms
 conditions in the name of the company/organisation:

Name: 
Date: 
Signature: 
Booking is invalid without a signature
Agreed Price of the service
Industry Professional	 € 1595
 per delegate
18 € administration charge and 21% Dutch VAT will be applied
Payment is required within 7 working days
If you wish to pay in USD ($) or GBP (£) please contact us for more details.
In the name of Event Production s.r.o. I hereby declare Event Production s.r.o.
will adhere to this sales contract  terms  conditions
Eduard Vacula, Director

More Related Content

What's hot

Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...
Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...
Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...Canadian Patient Safety Institute
 
Extending Shared Decision Making to Maternity Care: Opportunities and Challenges
Extending Shared Decision Making to Maternity Care: Opportunities and ChallengesExtending Shared Decision Making to Maternity Care: Opportunities and Challenges
Extending Shared Decision Making to Maternity Care: Opportunities and ChallengesInformed Medical Decisions Foundation
 
Evolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USEvolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USOffice of Health Economics
 
Alert 2017 tejani - nbi resident mock code study-2017-updated
Alert 2017  tejani - nbi resident mock code study-2017-updatedAlert 2017  tejani - nbi resident mock code study-2017-updated
Alert 2017 tejani - nbi resident mock code study-2017-updatedINSPIRE_Network
 
POPULATION_HLTH_MGMT
POPULATION_HLTH_MGMTPOPULATION_HLTH_MGMT
POPULATION_HLTH_MGMTTony Fanelli
 
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...HxRefactored
 
Design as a Key Tool in Product Development: A Perspective on Transformation ...
Design as a Key Tool in Product Development: A Perspective on Transformation ...Design as a Key Tool in Product Development: A Perspective on Transformation ...
Design as a Key Tool in Product Development: A Perspective on Transformation ...Service Design Network
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016ipposi
 
Recruiting for Patient Engagement
Recruiting for Patient EngagementRecruiting for Patient Engagement
Recruiting for Patient EngagementCHICommunications
 
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...Service Design Network
 
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العمل
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العململتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العمل
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العملExcellence Dayz - ملتقى التميز المؤسسي
 
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centre
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centrePressure ulcer prevention hotel dieu shaver health and rehabilitation centre
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centreCanadian Patient Safety Institute
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
 
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
 
Falls collaborative case studies
Falls collaborative case studies Falls collaborative case studies
Falls collaborative case studies NHS Improvement
 

What's hot (20)

Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...
Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...
Introduction of the Measuring and Monitoring of Safety (Vincent) Framework to...
 
Extending Shared Decision Making to Maternity Care: Opportunities and Challenges
Extending Shared Decision Making to Maternity Care: Opportunities and ChallengesExtending Shared Decision Making to Maternity Care: Opportunities and Challenges
Extending Shared Decision Making to Maternity Care: Opportunities and Challenges
 
Evolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USEvolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the US
 
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...
Bar-Cohen - Effectively Representing the Advocate Perspective in Advisory Set...
 
When caring hurts; helping helpers heal
When caring hurts; helping helpers healWhen caring hurts; helping helpers heal
When caring hurts; helping helpers heal
 
Alert 2017 tejani - nbi resident mock code study-2017-updated
Alert 2017  tejani - nbi resident mock code study-2017-updatedAlert 2017  tejani - nbi resident mock code study-2017-updated
Alert 2017 tejani - nbi resident mock code study-2017-updated
 
POPULATION_HLTH_MGMT
POPULATION_HLTH_MGMTPOPULATION_HLTH_MGMT
POPULATION_HLTH_MGMT
 
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...
HXR 2016: Improving Care Experiences through Human-Centered Design - Katie Ab...
 
Design as a Key Tool in Product Development: A Perspective on Transformation ...
Design as a Key Tool in Product Development: A Perspective on Transformation ...Design as a Key Tool in Product Development: A Perspective on Transformation ...
Design as a Key Tool in Product Development: A Perspective on Transformation ...
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
 
Recruiting for Patient Engagement
Recruiting for Patient EngagementRecruiting for Patient Engagement
Recruiting for Patient Engagement
 
PEN Awards Webinar series 2 of 6
PEN Awards Webinar series 2 of 6PEN Awards Webinar series 2 of 6
PEN Awards Webinar series 2 of 6
 
15.03.05 hope network slides v2
15.03.05 hope network slides v215.03.05 hope network slides v2
15.03.05 hope network slides v2
 
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...
Re-imagining Prenatal Care as a Wellness Experience Through Service Design - ...
 
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العمل
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العململتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العمل
ملتقى التميز المؤسسي 2015 - اليوم الأول - بناء مستشفى: نظرة إجراء العمل
 
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centre
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centrePressure ulcer prevention hotel dieu shaver health and rehabilitation centre
Pressure ulcer prevention hotel dieu shaver health and rehabilitation centre
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
 
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
 
Falls collaborative case studies
Falls collaborative case studies Falls collaborative case studies
Falls collaborative case studies
 
Methods and Tools for Integrating Health Equity into Public Health Program Pl...
Methods and Tools for Integrating Health Equity into Public Health Program Pl...Methods and Tools for Integrating Health Equity into Public Health Program Pl...
Methods and Tools for Integrating Health Equity into Public Health Program Pl...
 

Viewers also liked

Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpread
Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpreadBruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpread
Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpreadTony Bernard
 
C for basic var
C for basic varC for basic var
C for basic var約銘 陳
 
H.S Machinery-2015Biomass pellet mill catalogue
H.S Machinery-2015Biomass pellet mill  catalogue H.S Machinery-2015Biomass pellet mill  catalogue
H.S Machinery-2015Biomass pellet mill catalogue Dara B.
 
Edge application pp
Edge application ppEdge application pp
Edge application ppmetavallo
 
C for FIRST LESSON
C for FIRST LESSONC for FIRST LESSON
C for FIRST LESSON約銘 陳
 
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYA
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYACHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYA
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYADerick Odhiambo
 
Bartlett et al Radiother Oncol 2014
Bartlett et al Radiother Oncol 2014Bartlett et al Radiother Oncol 2014
Bartlett et al Radiother Oncol 2014Freddie Bartlett
 

Viewers also liked (13)

BALS167
BALS167BALS167
BALS167
 
Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpread
Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpreadBruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpread
Bruce Power 160072_GuidetoBrucePowerReport_R000_lowresSpread
 
C for basic var
C for basic varC for basic var
C for basic var
 
H.S Machinery-2015Biomass pellet mill catalogue
H.S Machinery-2015Biomass pellet mill  catalogue H.S Machinery-2015Biomass pellet mill  catalogue
H.S Machinery-2015Biomass pellet mill catalogue
 
Edge application pp
Edge application ppEdge application pp
Edge application pp
 
C for format
C for formatC for format
C for format
 
C
CC
C
 
C for FIRST LESSON
C for FIRST LESSONC for FIRST LESSON
C for FIRST LESSON
 
作業1&2
作業1&2作業1&2
作業1&2
 
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYA
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYACHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYA
CHARTERED PERSONAL EXECUTIVE ASSISTANT - CPEA - MARCH 2016 NAIROBI KENYA
 
Mitos y leyendas
Mitos y leyendasMitos y leyendas
Mitos y leyendas
 
Mitos y leyendas
Mitos y leyendasMitos y leyendas
Mitos y leyendas
 
Bartlett et al Radiother Oncol 2014
Bartlett et al Radiother Oncol 2014Bartlett et al Radiother Oncol 2014
Bartlett et al Radiother Oncol 2014
 

Similar to BALS18222

SMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceSMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceDale Butler
 
Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018ipposi
 
SMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceSMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceDale Butler
 
Carol Munt - 'patients as partners'
Carol Munt - 'patients as partners' Carol Munt - 'patients as partners'
Carol Munt - 'patients as partners' ipposi
 
SMi Group's 6th annual COPD conference
SMi Group's 6th annual COPD conferenceSMi Group's 6th annual COPD conference
SMi Group's 6th annual COPD conferenceDale Butler
 
Healthcare Innovation Summit 2014
Healthcare Innovation Summit 2014Healthcare Innovation Summit 2014
Healthcare Innovation Summit 2014Ali Zeeshan
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?HLGUK
 
SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018Dale Butler
 
SMi Group's Orphan Drugs and Rare Diseases 2019
SMi Group's Orphan Drugs and Rare Diseases 2019SMi Group's Orphan Drugs and Rare Diseases 2019
SMi Group's Orphan Drugs and Rare Diseases 2019Dale Butler
 
Pulse'15_CanadianHealthCareLeadershipForum_Brochure
Pulse'15_CanadianHealthCareLeadershipForum_BrochurePulse'15_CanadianHealthCareLeadershipForum_Brochure
Pulse'15_CanadianHealthCareLeadershipForum_BrochureSamanta Farahnaz
 
Telehealth for the Underserved & Medicaid Population
Telehealth for the Underserved & Medicaid PopulationTelehealth for the Underserved & Medicaid Population
Telehealth for the Underserved & Medicaid PopulationVSee
 
iWGC symposium 2016 slide deck
iWGC symposium 2016 slide deck iWGC symposium 2016 slide deck
iWGC symposium 2016 slide deck Emily Fovargue
 
Arab Neonatal Medical Congress Brochure v8
Arab Neonatal Medical Congress Brochure v8Arab Neonatal Medical Congress Brochure v8
Arab Neonatal Medical Congress Brochure v8Doaa Said
 

Similar to BALS18222 (20)

SMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceSMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conference
 
Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018
 
SMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceSMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conference
 
Carol Munt - 'patients as partners'
Carol Munt - 'patients as partners' Carol Munt - 'patients as partners'
Carol Munt - 'patients as partners'
 
SMi Group's 6th annual COPD conference
SMi Group's 6th annual COPD conferenceSMi Group's 6th annual COPD conference
SMi Group's 6th annual COPD conference
 
Healthcare Innovation Summit 2014
Healthcare Innovation Summit 2014Healthcare Innovation Summit 2014
Healthcare Innovation Summit 2014
 
5 year impact report for Rare Diseases
5 year impact report for Rare Diseases 5 year impact report for Rare Diseases
5 year impact report for Rare Diseases
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?
 
P 113 geriatric
P 113 geriatricP 113 geriatric
P 113 geriatric
 
SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018
 
SMi Group's Orphan Drugs and Rare Diseases 2019
SMi Group's Orphan Drugs and Rare Diseases 2019SMi Group's Orphan Drugs and Rare Diseases 2019
SMi Group's Orphan Drugs and Rare Diseases 2019
 
Pulse'15_CanadianHealthCareLeadershipForum_Brochure
Pulse'15_CanadianHealthCareLeadershipForum_BrochurePulse'15_CanadianHealthCareLeadershipForum_Brochure
Pulse'15_CanadianHealthCareLeadershipForum_Brochure
 
Webinar: Patient Engagement
Webinar: Patient EngagementWebinar: Patient Engagement
Webinar: Patient Engagement
 
0200 Anada Plate - Welcome to the WECAN Masterclass
0200 Anada Plate - Welcome to the WECAN Masterclass0200 Anada Plate - Welcome to the WECAN Masterclass
0200 Anada Plate - Welcome to the WECAN Masterclass
 
Telehealth for the Underserved & Medicaid Population
Telehealth for the Underserved & Medicaid PopulationTelehealth for the Underserved & Medicaid Population
Telehealth for the Underserved & Medicaid Population
 
Práticas Avançadas em Enfermagem no Reino Unido
Práticas Avançadas em Enfermagem no Reino UnidoPráticas Avançadas em Enfermagem no Reino Unido
Práticas Avançadas em Enfermagem no Reino Unido
 
iWGC symposium 2016 slide deck
iWGC symposium 2016 slide deck iWGC symposium 2016 slide deck
iWGC symposium 2016 slide deck
 
Arab Neonatal Medical Congress Brochure v8
Arab Neonatal Medical Congress Brochure v8Arab Neonatal Medical Congress Brochure v8
Arab Neonatal Medical Congress Brochure v8
 
AstuteDoctor Overview
AstuteDoctor OverviewAstuteDoctor Overview
AstuteDoctor Overview
 
DFCM Pearls: What is New
DFCM Pearls: What is NewDFCM Pearls: What is New
DFCM Pearls: What is New
 

BALS18222

  • 1. www.flemingeurope.com Organized by MEET THE MEMBERS OF OUR SPEAKER PANEL Lisa Egbuonu-Davis MD, MPH, MBA, Sanofi, USA Vice President Global Patient Centered Outcomes and Solutions Elizabeth Adams Irish Nurses and Midwives Organisation, Ireland Director of Professional Development Giora Sharf CML Advocate Network, Israel Patient Advocate and Board Member Michael Seres The Patient Association, UK Patient Ambassador See the whole speaker panel on the second page BENEFITS OF ATTENDING • Learn from UCB how to effectively engage patients • Get inspired by the award winning project Connecting Nurses by Sanofi • Discover what it means to be a patient in the 21st century • Learn about the daily challenges influencing adherence of chronic patients from patients themselves • Get your hands on practical advice from Teva on building an effective patient support team • Gain insight into the world of adherence digital health media SPECIAL FEATURES • fast-fire session • award-winning case study • workshop • roundtable discussions • hands-on try-out of digital health applications • spotlight session Media Partners 25 - 26 February 2016 Amsterdam THE NETHERLANDS Patient Adherence and Compliance Masterclass „Join forces with other stakeholders and make progress in improving adherence.“
  • 2. MASTERCLASS INTRODUCTION The pharmaceutical industry is undergoing changes, and is shifting towards patient centricity. Innovative outlooks and patient insights bring a new weapon to the battle against established challenges. Non-adherence increases medical costs, creates waste in medical spending, multiplies the number of hospitalisations and threatens lives. The issue touches all stakeholders involved in healthcare: from the pharmaceutical companies to doctors to the patients themselves. Therefore, effective improvement is possible only through the cooperation of multiple stakeholders. Improve stakeholder collaboration, build lasting relationships, learn about the challenges of others and improve adherence for the benefit of all. Whether you are an industry representative, a medical doctor, a health insurance representative or a member of a patient organisation, the Patient Adherence and Compliance Masterclass is the perfect opportunity to join forces with other stakeholders and make progress in improving adherence. SPEAKER PANEL Lisa Egbuonu-Davis MD, MPH, MBA Sanofi, USA Vice President Global Patient Centered Outcomes and Solutions Sylvie Coumel Sanofi, France Connecting Nurses & Patient Empowerment Director Global Patient- Centered Outcomes and Solutions Danielle Derijcke UCB, Belgium Patient Affairs Officer Elizabeth Adams Irish Nurses and Midwives Organisation, Ireland Director of Professional Development Rebecca Reeve Sanofi, UK Head of Professional Relations, Diabetes Søren Eik Skovlund Novo Nordisk, Denmark Global Director, Global Senior Health Economics and Outcomes Research Manager, DAWN Studies Ana Maria Arboleda Teva Europe Director of Operations, Patient Solutions Europe Natalia Forsyth Novartis, Switzerland Digital Health Strategist Dr. Stefan Becker University Hospital Essen Germany Consultant Physician Rachel Jones AstraZeneca, UK Patient Centricity Project lead, Qualified Pharmacist Marcel Kooij Utrecht University The Netherlands Pharmacist Giora Sharf CML Advocate Network, Israel Patient Advocate and Board Member Bettina Ryll Melanoma Patient Network Europe, Sweden Founder Michael Seres The Patient Association, UK Patient Ambassador Paul Buchanan Team Blood Glucose, UK CEO and Founder David SANgster 1in20Parkinsons, UK Founder Jerry van Gessel Parkinson‘s on the Move The Netherlands Board Member Joep Welling NVLE – The Dutch Patient Organization for Systemic Autoimmune Diseases The Netherlands Chair and former President Lia Le Roy Brain Tumor Support Group, The Netherlands Chair YOU WILL MEET Patients‘ Groups, Organizations and Associations, Pharmacists, Medical Doctors and Healthcare Providers, Medical Associations and Organizations, C-level Pharmaceutical Industry Executives along with Directors, Heads and Managers of: Patient Engagement, Support, Advocacy, Communication, Experience, Affairs, Adherence, Relationships, Assistance and others... Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490 Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
  • 3. DAY 1 8:30 MORNING COFFEE REGISTRATION 9:00 WELCOME NOTE FROM FLEMING EUROPE 9:05 OPENING REMARKS FROM THE CHAIRMAN UNDERSTANDING ADHERENCE FROM THE PATIENT‘S PERSPECTIVE 9:15 FAST-FIRE SESSION 20 very fast “YES/NO” questions addressed by the masterclass keynote speaker 9:20 KEYNOTE: THE MULTI-DIMENSIONAL ISSUE OF PATIENT ADHERENCE • The need for a multi-perspective approach • Reasons for non-adherence • Creating links and relationships between stakeholders 9:50 PATIENT EMPOWERMENT: MAKE PATIENTS YOUR PARTNERS IN HEALTHCARE • Educating patients and making them confident about their treatment • Advocating adherence on all platforms • Tips for building patient-centric content • QA Lisa Egbuonu-Davis MD, MPH, MBA, Sanofi, USA Vice President Global Patient Centered Outcomes and Solutions 10:20 HOW TO PREPARE YOUR ORGANIZATION FOR EFFECTIVE PATIENT ENGAGEMENT • Ingredients for successful patient engagement • Compliance to regulations • Ready, set, engage! Danielle Derijcke, UCB, Belgium Patient Affairs Officer 10:50 MORNING COFFEE NETWORKING 11:10 THE 21st CENTURY PATIENT • What does it mean to be a long term patient in the 21st Century • How does technology play a role • Are co-production and shared outcomes buzz words or a reality • How do patients share their data now Michael Seres, The Patient Association, UK Patient Ambassador 11:40 A DAY IN THE LIFE OF A PATIENT WITH A CHRONIC ILLNESS • Focus on the daily challenges brought by a strict medication regime • Learning about the individual needs of chronic patients • What needs to be done to manage non-adherence • QA David Sangster, 1in20Parkinsons, UK, Founder Paul Buchanan, Team Blood Glucose, UK CEO and Founder Jerry van Gessel, Parkinson‘s on the Move The Netherlands, Board Member Michael Seres, The Patient Association, UK Patient Ambassador 12:20 LUNCHEON 13:40 ROUNDTABLE DISCUSSION • Topic 1. The Role and Importance of Patient Support Groups in Battling Non-adherence • Topic 2. The Engagement of Patients in Research and Development • Topic 3. A Family Perspective on Chronic Disease and Adherence • Topic 4. Patient Education: The Key to Better Disease Management and Finding the Correct Treatment Lia Le Roy, Brain Tumor Support group The Netherlands, Chair Rachel Jones, AstraZeneca, UK, Patient Centricity Project Lead, Qualified Pharmacist Jerry van Gessel, Parkinson‘s on the Move The Netherlands, Board Member Joep Welling, NVLE – The Dutch Patient Organization for Systemic Autoimmune Diseases the Netherlands, Chair and former President MEDICATION ADHERENCE AND DIGITAL MEDIA 14:30 ENGAGING PATIENTS THROUGH DIGITAL HEALTH MEDIA • The priceless opportunity of getting real-time feedback • Using detailed data to create a personalized regime • Pinpointing the best digital health media and ideas for their application • QA Natalia Forsyth, Novartis, Switzerland Digital Health Strategist Paul Buchanan, Team Blood Glucose, UK CEO and Founder David Sangster, 1in20Parkinsons, UK, Founder 15:10 GAMIFIED ADHERENCE: DIGITAL HEALTH APPLICATIONS • Practical demonstrations • Hands-on try-out • QA Rebecca Reeve, sanofi-aventis, UK Head of Professional Relations, Diabetes 15:40 COFFEE BREAK NETWORKING 16:00 IMPROVING ADHERENCE BY mHEALTH • Can mHealth technology support chronically ill patients in the management of their disease and improve adherence? • Technical adherence as a precondition for medical adherence: Can we predict, who will use such technology long-term? • How can we evaluate such interventions? Dr. Stefan Becker, University Hospital Essen, Germany Consultant Physician 16:30 DISCUSSION: THE MOST SUCCESSFUL WAYS OF APPROACHING PATIENTS Approaching patients and getting valuable insights represents one of the biggest problems in creating adherence solutions. Adopt an ethical approach and learn from industry leaders about the best ways to reach customers. Featuring speakers from day1 Topics to be covered and discussed: • The need for an ethical approach to patients • The key principles of Trust and Respect • Practical methods for gaining patients‘ insights 17:55 FEEDBACK SESSION 17:55 CLOSING REMARKS FROM THE CHAIR 18:00 Speakers and delegates are cordially invited to attend a NETWORKING COCKTAIL RECEPTION compliments of FLEMING EUROPE Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490 Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
  • 4. 8:30 MORNING COFFEE NETWORKING 9:00 OPENING REMARKS FROM THE CHAIR MULTIPLE-STAKEHOLDER COOPERATION 9:05 IMPROVING ADHERENCE THROUGH SUSTAINABLE STAKEHOLDER COLLABORATION • Communication with various stakeholders • Building sustainable, people-centred and collaborative health care • Applying the principles of transparency and communication in practice Søren Eik Skovlund, Novo Nordisk, Denmark Global Director, Global Senior Health Economics and Outcomes Research Manager, DAWN Studies 9:30 AWARD-WINNING CASE STUDY: CONNECTING NURSES Learn about the ideas behind the winner of the Ad Age Healthcare Impact GOLD Award, making it possible for the nurse community to share valuable content and implement ideas improving healthcare worldwide. Sylvie Coumel, Sanofi, France Connecting Nurses Patient Empowerment Director Global Patient-Centered Outcomes and Solutions 10:00 SUPPORTING PATIENTS: PHARMACY BASED INTERVENTIONS TO IMPROVE MEDICATION ADHERENCE • The role of pharmacists in improving adherence • Building a relationship with the patients • Succesful Interventions in a pharmacy • QA Marcel Kooij, Utrecht University, The Netherlands Pharmacist 10:30 MORNING COFFEE NETWORKING 11:00 SUPPORT, CARE AND UNDERSTANDING: NURSES AND ADHERENCE • A direct and personal approach to patients • Professional development of nurses in the new era of healthcare • Improving health literacy and overcoming adherence barriers Elizabeth Adams, Irish Nurses and Midwives Organisation, Ireland, Director of Professional Development IMPROVING ADHERENCE 11:35 ADHERENCE IN CML: RESEARCH BY THE CML ADVOCATES NETWORK • Results of an extensive study of over 2500 CML patients in 79 countries • Reasons for non-adherence • Possible solutions based on the results Giora Sharf, CML Advocate Network, Israel Patient Advocate and Board Member 12:00 LUNCHEON 13:30 METHODOLOGY OF MEANINGFUL INTERACTION • Understanding adherence and non-adherence • Prevalent misconceptions about patients’ motivation • Addressing the underlying issues and increasing intrinsic motivation Bettina Ryll, Melanoma Patient Network Europe, Sweden, Founder 14:00 WORKSHOP: HOW TO CREATE AN EFFECTIVE PATIENT SUPPORT TEAM Employ your strategic thinking and get valuable advice from successful professionals at an interactive session on stakeholder involvement within the circle of patient care Topics to be covered and discussed: • Discuss the best support team structure and program goals • Learn how to achieve better self-management and adherence rates • Discover solutions which help to overcome treatment issues Workshop leader: Ana Maria Arboleda, Teva Europe Director of Operations, Patient Solutions Europe 15:35 FEEDBACK SESSION 15:45 CLOSING REMARKS FROM THE CHAIR 15:50 FAREWELL COFFEE TEA I would like to thank everyone who has helped with the research and organization of this event – especially the advisers and speakers – for their support and commitment. Stanislava Nichtova, Conference and Masterclass Producer stanislava.nichtova@flemingeurope.com DAY 2Booking line: Tel: +421 257 272 290 | Fax: +421 255 644 490 Email: killian.mabena@flemingeurope.com | www.flemingeurope.com
  • 5. Patient Adherence and Compliance Masterclass 25 - 26 February 2016, Amsterdam, THE NETHERLANDS Terms and Conditions: These terms and conditions represent an integral part of this contract between Event Production, s.r.o. and a client, which is specified above, and who by signing this registration form fully and without any doubt or uncertainty accepts all following terms and conditions: 1. Payment terms. Event Production, s.r.o. (hereinafter as “EP”) requires the full payment of the invoiced amount within 7 working days from the issue date of the invoice. EP reserves the right to refuse entry to any client who does not pay the invoice in full and on time. If the payment is not received on EP’s account on the seventh day from the date of the issue of the invoice, EP is entitled to charge the Client an overdue interest of 5% p.a. for every day, for which the Cleint’s payment is overdue. The registration fee includes: conference documentation, admission to all conference sessions, lunches and refreshments, admission to networking social breaks during the event. The registration fee does not include: travel, hotel accommodation, transfers or insurance. 2. Hotel accommodation. Overnight accommodation is not included in the registration fee. A reduced rate may be available for EP’s clients at the hotel hosting the event. The reservation form will be sent to the client after the venue has been confirmed, but no later than one month before the event begins. 3. Cancellation by client. The client has the right to cancel his/her participation in the event. Cancellation must be received by EP in writing, either by mail, email or fax. If the client cancels with more than one month’s advance notice before the start of the event, EP shall be entitled to retain and charge 50% of the total invoiced amount. If the client cancels with one month’s (or less) advance notice, or fails to attend the event, then the client shall not be entitled to any refund nor any discount. Client’s failure to attend the event does not cancel, decrease or in any matter waives the client’s obligation to fully pay the fee invoiced to the client by EP. 4. Cancellation by EP. While every reasonable effort is made to adhere to the advertised program, circumstances out of the control of EP can arise, which may cause changes in the program, including but not limited to changes in the content, date(s), location or venue, or special features of the planned event. Such circumstances include but are not limited to acts of terrorism, war, extreme weather conditions, compliance with government requests, orders and legal requirements, failure of third party suppliers to timely deliver, and failure to register the minimum targeted amount of attendees for a given event. EP reserves the right to change the content, date(s), location or venue and/or special features of an event, to merge the event with another event, or to postpone it or cancel it entirely as appropriate under the circumstances. Client agrees that EP shall not be liable for any cost, damage or expense which may be incurred by client as a consequence of the event being changed, merged with another event, postponed or cancelled and client agrees to hold EP harmless and to indemnify EP for any liability caused by any such changes, mergers, postponements or cancellations to the Client. 5. Cancellation of the event. In case EP cancels the event, EP may offer the client a full credit up to the amount actually paid by the client to EP. This credit shall be valid for up to one year from the issue date of the invoice to attend any of EP’s events. The client shall not be entitled to this credit as a contractual right. 6. Clients identification information. By signing of this sales contract and these terms and conditions the client gives full right to EP to share the client’s identification information such as, but not limited to, client’s name, address, email addresses, phone numbers and names of representatives with third parties, which participated on the same event as the client. 7. Governing law. This contract shall be governed and construed in accordance with the laws of the Slovak Republic (not including its conflict of laws provisions). Any disputes arising out of this contract shall be brought before the courts of the Slovak Republic situated in the city of Bratislava in the Slovak Republic. 8. Other currencies. In case that client requests payment in other than EP’s official currency (EUR), EP reserves the right to apply 8% currency risk surcharge to the actual exchange rate. Mlynské Nivy 71, 821 05 Bratislava, Slovakia IČO: 44 59 74 52, IČ DPH: SK2022754448 1 Sales Contract Conference Code: BALS181 Please complete this form and send it back to: E-mail to: killian.mabena@flemingeurope.com or FAX.: + 421 255 644 490 Client Identification Details (Please complete form IN CAPITAL LETTERS for each client) Ms Mrs Mr Surname: Name: Job Title: Email: Ms Mrs Mr Surname: Name: Job Title: Email: Ms Mrs Mr Surname: Name: Job Title: Email: Company/organisation Details Name: VAT Number: (VAT No. for EU members / Tax Number for non-EU members) Contact person: Email: Address: City: Country: Phone: Under European Union and Dutch tax regulations delegates are required to pay VAT in any conference taking place in Netherlands. Delegates may be entitled to reclaim this cost. Payment Method Please debit my Visa Eurocard/Mastercard Diners club Card Billing Address: Street: City: Post/Zip Code Card Holder´s Name: Card Holder´s Signature: Card Number: Visa CVC Number or Eurocard/Mastercard CVV Number (last 3 digits on the back of the card) Valid from Expiry Date I agree to Event Production s.r.o. debiting my card. Authorization and Acceptance of Sales contract Terms Conditions I hereby declare I am authorised to sign this contract and terms conditions in the name of the company/organisation: Name: Date: Signature: Booking is invalid without a signature Agreed Price of the service Industry Professional € 1595 per delegate 18 € administration charge and 21% Dutch VAT will be applied Payment is required within 7 working days If you wish to pay in USD ($) or GBP (£) please contact us for more details. In the name of Event Production s.r.o. I hereby declare Event Production s.r.o. will adhere to this sales contract terms conditions Eduard Vacula, Director